Clinical trial
Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes
NCT00398853 · Pennington Biomedical Research Center, Other · Completed
Key facts
| NCT number | NCT00398853 |
|---|---|
| Title | Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes |
| Official title | Chromium and Insulin Action |
| Lead sponsor | Pennington Biomedical Research Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Dietary Supplement, Other |
| Interventions | chromium picolinate 1000 mcg daily vs placebo, Placebo |
| Enrollment | 100 |
| Start date | Oct 1, 2003 |
| Primary completion | Apr 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 14, 2006 |
| Last update posted | Apr 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: